ARCHIVES

Proflavine Bioassay Ineffective, NCI Says

This article is from The Cancer Letter archive.

Vol. 03 No. 28 | July 15, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve New Grant Programs Worth $100 Million

March 27, 2009

Bailes: ASCO To Strengthen State Affiliates, Begin Quality Of Care Study, Talk With FDA.

May 26, 2000

Breast Cancer Family History Doesn’t Increase Risk Of Ovarian Cancer, Study Says

September 30, 2005

NIH Challenge Grant Announcement

March 6, 2009

In Brief: Gifts to NCI Totaled $332,226 In Fiscal 1986; Position Freeze Said To Hurt DCE Labs

January 3, 1986

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010